5-Nov-2025 1:54 AM CST - Seeking Alpha Municipal Bonds: I'm Choosing HYMB Over HYD Nuveen ICE High Yield Municipal Bond offers higher yields & better risk-adjusted returns despite a slightly higher expense ratio and increased volatility vs. HYD. Learn more about HYD here.
1-Jul-2025 7:55 PM CST - Seeking Alpha HOOY: 100% Dividend Yield Isn't Worth Entering At The Highs YieldMax HOOD Option Income Strategy ETF offers massive yields by harnessing Robinhood's volatility. Read more on the potential and risks of HOOY ETF here.
29-May-2025 11:00 AM CST - Seeking Alpha HYIN WisdomTree Alternative Income Fund ETF A high-level overview of WisdomTree Alternative Income Fund ETF (HYIN). Stay up to date on the latest price, chart, news, analysis, fundamentals, trading and investment tools.
13-May-2025 1:10 PM CST - Reuters Hinge Health targets $3 billion valuation as IPO markets signal comeback Digital health startup Hinge Health said on Tuesday it is targeting a valuation of up to $2.98 billion on a fully diluted basis in its initial public offering, signaling thawing of the U.S. IPO market after recent market volatility.
5-Nov-2025 1:54 AM CST - Seeking Alpha Municipal Bonds: I'm Choosing HYMB Over HYD Nuveen ICE High Yield Municipal Bond offers higher yields & better risk-adjusted returns despite a slightly higher expense ratio and increased volatility vs. HYD. Learn more about HYD here.
1-Jul-2025 7:55 PM CST - Seeking Alpha HOOY: 100% Dividend Yield Isn't Worth Entering At The Highs YieldMax HOOD Option Income Strategy ETF offers massive yields by harnessing Robinhood's volatility. Read more on the potential and risks of HOOY ETF here.
29-May-2025 11:00 AM CST - Seeking Alpha HYIN WisdomTree Alternative Income Fund ETF A high-level overview of WisdomTree Alternative Income Fund ETF (HYIN). Stay up to date on the latest price, chart, news, analysis, fundamentals, trading and investment tools.
13-May-2025 1:10 PM CST - Reuters Hinge Health targets $3 billion valuation as IPO markets signal comeback Digital health startup Hinge Health said on Tuesday it is targeting a valuation of up to $2.98 billion on a fully diluted basis in its initial public offering, signaling thawing of the U.S. IPO market after recent market volatility.